Wei Perng1,2,3, Brandy M Ringham4, Harry A Smith4,5, Gregory Michelotti6, Katerina M Kechris5, Dana Dabelea4,7,8. 1. Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Room 208, 12474 E. 19th Ave, Aurora, CO, 80045, USA. Wei.Perng@CUAnschutz.edu. 2. Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Wei.Perng@CUAnschutz.edu. 3. Department of Nutritional Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, USA. Wei.Perng@CUAnschutz.edu. 4. Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Room 208, 12474 E. 19th Ave, Aurora, CO, 80045, USA. 5. Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 6. Metabolon, Inc., Chapel Hill, NC, USA. 7. Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 8. Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract
AIMS/HYPOTHESIS: This study aimed to: (1) identify metabolite patterns during late childhood that differ with respect to exposure to maternal gestational diabetes mellitus (GDM); (2) examine the persistence of GDM/metabolite associations 5 years later, during adolescence; and (3) investigate the associations of metabolite patterns with adiposity and metabolic biomarkers from childhood through adolescence. METHODS: This study included 592 mother-child pairs with information on GDM exposure (n = 92 exposed), untargeted metabolomics data at age 6-14 years (T1) and at 12-19 years (T2), and information on adiposity and metabolic risk biomarkers at T1 and T2. We first consolidated 767 metabolites at T1 into factors (metabolite patterns) via principal component analysis (PCA) and used multivariable regression to identify factors that differed by GDM exposure, at α = 0.05. We then examined associations of GDM with individual metabolites within factors of interest at T1 and T2, and investigated associations of GDM-related factors at T1 with adiposity and metabolic risk throughout T1 and T2 using mixed-effects linear regression models. RESULTS: Of the six factors retained from PCA, GDM exposure was associated with greater odds of being in quartile (Q)4 (vs Q1-3) of 'Factor 4' at T1 after accounting for age, sex, race/ethnicity, maternal smoking habits during pregnancy, Tanner stage, physical activity and total energy intake, at α = 0.05 (OR 1.78 [95% CI 1.04, 3.04]; p = 0.04). This metabolite pattern comprised phosphatidylcholines, diacylglycerols and phosphatidylethanolamines. GDM was consistently associated with elevations in a subset of individual compounds within this pattern at T1 and T2. While this metabolite pattern was not related to the health outcomes in boys, it corresponded with greater adiposity and a worse metabolic profile among girls throughout the follow-up period. Each 1-unit increment in Factor 4 corresponded with 0.17 (0.08, 0.25) units higher BMI z score, 8.83 (5.07, 12.59) pmol/l higher fasting insulin, 0.28 (0.13, 0.43) units higher HOMA-IR, and 4.73 (2.15, 7.31) nmol/l higher leptin. CONCLUSIONS/ INTERPRETATION: Exposure to maternal GDM was nominally associated with a metabolite pattern characterised by elevated serum phospholipids in late childhood and adolescence at α = 0.05. This metabolite pattern was associated with greater adiposity and metabolic risk among female offspring throughout the late childhood-to-adolescence transition. Future studies are warranted to confirm our findings.
AIMS/HYPOTHESIS: This study aimed to: (1) identify metabolite patterns during late childhood that differ with respect to exposure to maternal gestational diabetes mellitus (GDM); (2) examine the persistence of GDM/metabolite associations 5 years later, during adolescence; and (3) investigate the associations of metabolite patterns with adiposity and metabolic biomarkers from childhood through adolescence. METHODS: This study included 592 mother-child pairs with information on GDM exposure (n = 92 exposed), untargeted metabolomics data at age 6-14 years (T1) and at 12-19 years (T2), and information on adiposity and metabolic risk biomarkers at T1 and T2. We first consolidated 767 metabolites at T1 into factors (metabolite patterns) via principal component analysis (PCA) and used multivariable regression to identify factors that differed by GDM exposure, at α = 0.05. We then examined associations of GDM with individual metabolites within factors of interest at T1 and T2, and investigated associations of GDM-related factors at T1 with adiposity and metabolic risk throughout T1 and T2 using mixed-effects linear regression models. RESULTS: Of the six factors retained from PCA, GDM exposure was associated with greater odds of being in quartile (Q)4 (vs Q1-3) of 'Factor 4' at T1 after accounting for age, sex, race/ethnicity, maternal smoking habits during pregnancy, Tanner stage, physical activity and total energy intake, at α = 0.05 (OR 1.78 [95% CI 1.04, 3.04]; p = 0.04). This metabolite pattern comprised phosphatidylcholines, diacylglycerols and phosphatidylethanolamines. GDM was consistently associated with elevations in a subset of individual compounds within this pattern at T1 and T2. While this metabolite pattern was not related to the health outcomes in boys, it corresponded with greater adiposity and a worse metabolic profile among girls throughout the follow-up period. Each 1-unit increment in Factor 4 corresponded with 0.17 (0.08, 0.25) units higher BMI z score, 8.83 (5.07, 12.59) pmol/l higher fasting insulin, 0.28 (0.13, 0.43) units higher HOMA-IR, and 4.73 (2.15, 7.31) nmol/l higher leptin. CONCLUSIONS/ INTERPRETATION: Exposure to maternal GDM was nominally associated with a metabolite pattern characterised by elevated serum phospholipids in late childhood and adolescence at α = 0.05. This metabolite pattern was associated with greater adiposity and metabolic risk among female offspring throughout the late childhood-to-adolescence transition. Future studies are warranted to confirm our findings.
Authors: Daniel A Enquobahrie; Marie Denis; Mahlet G Tadesse; Bizu Gelaye; Habtom W Ressom; Michelle A Williams Journal: J Clin Endocrinol Metab Date: 2015-09-25 Impact factor: 5.958
Authors: Joana Pinto; Lara M Almeida; Ana S Martins; Daniela Duarte; António S Barros; Eulália Galhano; Cristina Pita; Maria do Céu Almeida; Isabel M Carreira; Ana M Gil Journal: J Proteome Res Date: 2015-05-08 Impact factor: 4.466
Authors: T L Crume; L Ogden; N A West; K S Vehik; A Scherzinger; S Daniels; R McDuffie; K Bischoff; R F Hamman; J M Norris; D Dabelea Journal: Diabetologia Date: 2010-10-17 Impact factor: 10.122
Authors: Michael A Polewski; Maggie S Burhans; Minghui Zhao; Ricki J Colman; Dhanansayan Shanmuganayagam; Mary J Lindstrom; James M Ntambi; Rozalyn M Anderson Journal: J Lipid Res Date: 2015-06-10 Impact factor: 5.922
Authors: Ghattu V Krishnaveni; Sargoor R Veena; Jacqueline C Hill; Sarah Kehoe; Samuel C Karat; Caroline H D Fall Journal: Diabetes Care Date: 2009-11-16 Impact factor: 19.112
Authors: Wei Perng; Ellen C Francis; Harry A Smith; John Carey; Dongqing Wang; Katerina M Kechris; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: David Burgner; Richard Saffery; Toby Mansell; Amanda Vlahos; Fiona Collier; Anne-Louise Ponsonby; Peter Vuillermin; Susan Ellul; Mimi L K Tang Journal: Pediatr Res Date: 2021-09-15 Impact factor: 3.953
Authors: Catherine C Cohen; Dana Dabelea; Gregory Michelotti; Lu Tang; Kartik Shankar; Michael I Goran; Wei Perng Journal: Metabolites Date: 2022-06-17
Authors: Margot De Spiegeleer; Ellen De Paepe; Lieven Van Meulebroek; Inge Gies; Jean De Schepper; Lynn Vanhaecke Journal: Mol Med Date: 2021-11-06 Impact factor: 6.354